American Cannabis Company Announces Its Las Vegas Client, TGIG, Begins Operations
- March 22, 2016
- Posted by: steven
- Category: Uncategorized
DENVER, CO / ACCESSWIRE / March 22, 2016 / American Cannabis Company, Inc. (OTCQB: AMMJ) (the “Company”), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced its Las Vegas client, TGIG, has initiated cultivation and processing operations at its production facility, and opened its first dispensary, The Grove, in Pahrump, Nev. The second dispensary for The Grove, located just minutes from McCarran Airport and the Las Vegas Strip, is slated for an April grand opening.
Corey Hollister, president and CEO, American Cannabis Company, commented: “We are very excited for our client to cross these significant milestones. TGIG’s commitment to excellence and quality made them an ideal client. The company arguably has built the most state-of-the-art cannabis cultivation facility in the world, with the determined goal of being the highest quality producer in Las Vegas and throughout Southern Nevada.”
“From So-hum Living SoilTM based production, to vertical and horizontal gain through the High Density Cultivation SystemTM (HDCS), to LED lighting and intensive bio-security, TGIG capitalized on all areas of opportunity. As we approach our second year since beginning the application process, going through buildout and deployment and now into operations, it’s has been a tremendous relationship,” Hollister added.
“Our goal was to create a facility unlike any other in our market. It is, in some ways, first of its kind on this scale,” said TGIG CEO Demetri Kouretas. “It has been extremely helpful to have the guidance of American Cannabis Company through the application and licensing process, as well as their assistance in setting up our various operations.”
For a view of the cultivation/processing facility visit our website at www.americancannabiscompanyinc.com and watch the video on the homepage.
About American Cannabis Company, Inc.:
American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. Through our two vertically integrated businesses, American Cannabis Consulting and American Cultivator Company, a group purchasing organization, we support our clients from concept to creation to commercialization to on-going operations.
For more information, please visit: www.americancannabiscompanyinc.com.
TGIG is a vertically integrated medical marijuana enterprise that has brought together a team of experts who bring an extensive depth of knowledge in myriad industries, such as medical and horticultural, as well as culinary and the cannabis oil industry, and is applying this experience to its operations. TGIG operates a state-of-the-art cultivation and production facility and is dedicated to curating its selection of strains so it can not only offer those that are most in demand by its clients, but also those that are difficult to find and highly sought after. The company operates The Grove medical marijuana dispensaries in Nevada with two locations: one in Las Vegas located at 4640 Paradise Road just minutes from McCarran Airport and the famous Las Vegas Strip, and the only licensed dispensary in Nye County, at 1541 E. Basin Ave, Pahrump, Nev.
Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward- looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.
Chief Operating Officer